- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
July 15, 2014 (Reuters) -- Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics to track their blood glucose levels or restore the eye's ability to focus.
The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The technology is poten
July 8, 2014 (Reuters) -- Sanofi said on Tuesday the U.S. Food and Drug Administration had accepted for review the filing of a new drug application for its diabetes drug Toujeo.
"With the FDA's acceptance of our submission, we are anticipating the regulatory decision for marketing authorization for Toujeo in the U.S. in the first half of 2015." said Pierre Chancel, Senior Vice President, Globa
June 23, 2014 (MedPage Today) -- Soy supplements won't send testosterone levels plummeting in men with type 2 diabetes who already have low levels of the hormone, researchers reported here.
Testosterone levels actually rose with supplementation with either a soy protein bar or a soy protein bar that also contained phytoestrogens, Thozhukat Sathyapalan, MBBS, MD, of Hull York Medical School in England, and colleagues reported at the joint meeting of the Endocrine Society and the International Congr
June 23, 2014 (HealthDay News) -- People who have heart disease or diabetes, the overweight or obese and former smokers are most likely to keep taking cholesterol-lowering statins, a new study finds.
Previous research has shown that as many 46 percent of patients who are prescribed statins stop taking them. Nearly one in 10 cardiovascular events are linked to failure to take prescribed drugs,
June 18, 2014 (HealthDay News) -- A new implant designed to curb the appetite by electrically stimulating stomach nerves may have moved closer to U.S. Food and Drug Administration approval on Tuesday.
The device is aimed at severely obese adults who have failed to slim down using traditional methods, but don't want, or can't have, weight-loss surgery, the device's manufacturer, EnteroMedics Inc.,